</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →
3002.13.00.10/Ranibizumab Monoclonal Antibody/Japan

Ranibizumab Monoclonal Antibody from Japan

Ranibizumab (Lucentis) affinity-matured humanized monoclonal antibody fragment for wet AMD. HTS 3002.13.0010 bulk unmixed biotech product. Includes fragments per chapter notes.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.05.860%Universal product exemption (U.S. note 52(b))
Calculate with your customs valueVerify classification with AI

Import Tips

• Ophthalmic-specific sterility tests required

• Fragment vs full antibody COA clarity